Byrne Asset Management’s Arcturus Therapeutics ARCT Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q4 | $111K | Buy |
|
|||||
|
2025
Q3 | $7.37K | Sell |
|
|||||
|
2025
Q2 | $38.5K | Buy |
|
|||||
|
2025
Q1 | – | Sell |
|
|||||
|
2024
Q4 | $25.8K | Sell |
|
|||||
|
2024
Q3 | $48.3K | Buy |
|
|||||
|
2024
Q2 | $45K | Sell |
|
|||||
|
2024
Q1 | $69.6K | Sell |
|
|||||
|
2023
Q4 | $76.3K | Sell |
|
|||||
|
2023
Q3 | $84K | Sell |
|
|||||
|
2023
Q2 | $100K | Sell |
|
|||||
|
2023
Q1 | $101K | Sell |
|
|||||
|
2022
Q4 | $110K | Buy |
|
|||||
|
2022
Q3 | $67K | Buy |
|
|||||
|
2022
Q2 | $74K | Buy |
|
|||||
|
2022
Q1 | $108K | Buy |
|
|||||
|
2021
Q4 | $114K | Buy |
|